发明名称 Monoamine reuptake inhibitors for treatment of central nervous system disorders
摘要 <p>The present invention relates to compounds that are useful exhibit activity as serotonin, norepinephrine and dopamine reuptake inhibitors, and their pharmaceutically acceptable salts, and their use in the treatment of central nervous system and other disorders.</p>
申请公布号 CZ20013023(A3) 申请公布日期 2002.02.13
申请号 CZ20010003023 申请日期 2000.02.02
申请人 PFIZER PRODUCTS INC. 发明人 ELLIOTT MARK LEONARD;HOWARD HARRY RALPH JR.;SCHMIDT CHRISTOPHER JOSEPH;SEEGER THOMAS FRANCIS
分类号 A61K31/135;A61P25/24;A61P25/28;C07C217/58;C07C217/90;C07C233/18;C07C235/34;C07C255/37;C07C255/59;C07C311/29;C07C317/32;C07C323/20;C07D207/08;C07D211/22;C07D265/30;C07D279/12;C07D295/096;(IPC1-7):C07C217/58;A61P25/00;C07D207/14 主分类号 A61K31/135
代理机构 代理人
主权项
地址